News
|
Careers
|
Contact Us
About Vanda
Development Pipeline
Discovery Research
Investor Relations
meet vanda
We are using pharmacogenetics to match promising molecules
to the right patients. So selecting the right medicine will be
easier, thanks to our more personal approach.
November 20, 2008
FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
October 30, 2008
Vanda Pharmaceuticals Reports Third Quarter 2008 Results
September 25, 2008
Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
September 11, 2008
Vanda Pharmaceuticals Provides Update on Iloperidone
Read More in the Newsroom
Iloperidone
VEC-162
VSF-173